首页> 美国卫生研究院文献>BMC Cancer >Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review
【2h】

Alterations in PGC1α expression levels are involved in colorectal cancer risk: a qualitative systematic review

机译:PGC1α表达水平的改变与大肠癌风险有关:系统性定性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundColorectal cancer (CRC) is a major global public health problem and the second leading cause of cancer-related death. Mitochondrial dysfunction has long been suspected to be involved in this type of tumorigenesis, as supported by an accumulating body of research evidence. However, little is known about how mitochondrial alterations contribute to tumorigenesis. Mitochondrial biogenesis is a fundamental cellular process required to maintain functional mitochondria and as an adaptive mechanism in response to changing energy requirements. Mitochondrial biogenesis is regulated by peroxisome proliferator-activated receptor gamma coactivator 1-α (PPARGC1A or PGC1α). In this paper, we report a systematic review to summarize current evidence on the role of PGC1α in the initiation and progression of CRC. The aim is to provide a basis for more comprehensive research.
机译:背景大肠癌(CRC)是全球主要的公共卫生问题,也是与癌症相关的死亡的第二大主要原因。长期以来,人们一直怀疑线粒体功能障碍与这种类型的肿瘤发生有关,得到了越来越多的研究证据的支持。然而,关于线粒体改变如何促成肿瘤发生还知之甚少。线粒体生物发生是维持功能性线粒体所需的基本细胞过程,并且是响应不断变化的能量需求的适应性机制。线粒体生物发生受过氧化物酶体增殖物激活的受体γ辅激活物1-α(PPARGC1A或PGC1α)的调节。在本文中,我们报告了系统综述,以总结有关PGC1α在CRC起始和进展中作用的最新证据。目的是为更全面的研究提供基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号